Bank of New York Mellon’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-558,522
Closed -$8.59M 4232
2025
Q4
$8.59M Sell
558,522
-49,621
-8% -$547K ﹤0.01% 2015
2025
Q3
$6.04M Sell
608,143
-83,745
-12% -$872K ﹤0.01% 2211
2025
Q2
$6.86M Sell
691,888
-199,158
-22% -$2.1M ﹤0.01% 2095
2025
Q1
$11.6M Sell
891,046
-40,282
-4% -$533K ﹤0.01% 1779
2024
Q4
$11.9M Buy
931,328
+39,513
+4% +$478K ﹤0.01% 1829
2024
Q3
$9.93M Sell
891,815
-85,188
-9% -$939K ﹤0.01% 1933
2024
Q2
$11M Buy
977,003
+42,404
+5% +$494K ﹤0.01% 1909
2024
Q1
$11.6M Sell
934,599
-68,566
-7% -$894K ﹤0.01% 1891
2023
Q4
$14M Sell
1,003,165
-356,564
-26% -$4.95M ﹤0.01% 1791
2023
Q3
$20.1M Buy
1,359,729
+231,731
+21% +$3.26M ﹤0.01% 1539
2023
Q2
$14.6M Sell
1,127,998
-4,811
-0.4% -$54.8K ﹤0.01% 1739
2023
Q1
$11.1M Sell
1,132,809
-40,384
-3% -$431K ﹤0.01% 1886
2022
Q4
$12.5M Buy
1,173,193
+145,917
+14% +$1.7M ﹤0.01% 1819
2022
Q3
$10.7M Buy
1,027,276
+35,940
+4% +$468K ﹤0.01% 1869
2022
Q2
$12.5M Buy
991,336
+636,580
+179% +$6.76M ﹤0.01% 1811
2022
Q1
$3.85M Sell
354,756
-14,641
-4% -$178K ﹤0.01% 2561
2021
Q4
$5.2M Sell
369,397
-33,754
-8% -$555K ﹤0.01% 2451
2021
Q3
$7.75M Buy
403,151
+84,849
+27% +$1.13M ﹤0.01% 2258
2021
Q2
$3.13M Sell
318,302
-87,607
-22% -$796K ﹤0.01% 2727
2021
Q1
$3.99M Sell
405,909
-15,843
-4% -$131K ﹤0.01% 2550
2020
Q4
$1.88M Buy
421,752
+2,994
+0.7% +$13.6K ﹤0.01% 2885
2020
Q3
$1.81M Buy
418,758
+38,318
+10% +$273K ﹤0.01% 2724
2020
Q2
$3.38M Buy
380,440
+33,090
+10% +$167K ﹤0.01% 2410
2020
Q1
$1.23M Sell
347,350
-20,332
-6% -$94.3K ﹤0.01% 2833
2019
Q4
$2.1M Buy
367,682
+74,969
+26% +$401K ﹤0.01% 2793
2019
Q3
$1.05M Buy
292,713
+28,022
+11% +$109K ﹤0.01% 3158
2019
Q2
$1.06M Sell
264,691
-11,531
-4% -$66.9K ﹤0.01% 3175
2019
Q1
$2.02M Buy
276,222
+410
+0.1% +$4.01K ﹤0.01% 2773
2018
Q4
$2.52M Buy
275,812
+416
+0.2% +$4.61K ﹤0.01% 2617
2018
Q3
$3.42M Sell
275,396
-99
-0% -$1.34K ﹤0.01% 2573
2018
Q2
$4.2M Sell
275,495
-28,922
-10% -$500K ﹤0.01% 2483
2018
Q1
$6.04M Buy
304,417
+2,047
+0.7% +$35.4K ﹤0.01% 2254
2017
Q4
$5.65M Sell
302,370
-57,280
-16% -$1.15M ﹤0.01% 2301
2017
Q3
$7.73M Buy
359,650
+108,788
+43% +$1.72M ﹤0.01% 2122
2017
Q2
$2.42M Buy
250,862
+73,866
+42% +$480K ﹤0.01% 2740
2017
Q1
$1.05M Buy
176,996
+6,623
+4% +$31.8K ﹤0.01% 3210
2016
Q4
$673K Buy
170,373
+3,066
+2% +$22.5K ﹤0.01% 3451
2016
Q3
$1.75M Sell
167,307
-20,626
-11% -$296K ﹤0.01% 2837
2016
Q2
$2.74M Sell
187,933
-12,133
-6% -$207K ﹤0.01% 2528
2016
Q1
$3.85M Sell
200,066
-6,159
-3% -$124K ﹤0.01% 2317
2015
Q4
$4.98M Sell
206,225
-39,699
-16% -$994K ﹤0.01% 2215
2015
Q3
$6.03M Buy
245,924
+12,906
+6% +$365K ﹤0.01% 2130
2015
Q2
$5.46M Buy
233,018
+39,585
+20% +$862K ﹤0.01% 2296
2015
Q1
$4.34M Buy
193,433
+49,960
+35% +$957K ﹤0.01% 2386
2014
Q4
$2.42M Buy
143,473
+744
+0.5% +$11.3K ﹤0.01% 2738
2014
Q3
$2.04M Buy
142,729
+17,598
+14% +$254K ﹤0.01% 2867
2014
Q2
$2M Sell
125,131
-14,840
-11% -$224K ﹤0.01% 2899
2014
Q1
$2.53M Buy
139,971
+9,510
+7% +$176K ﹤0.01% 2732
2013
Q4
$2.56M Buy
130,461
+39,642
+44% +$580K ﹤0.01% 2732
2013
Q3
$1.08M Buy
90,819
+81
+0.1% +$1.02K ﹤0.01% 3198
2013
Q2
$998K Buy
+90,738
New +$1.91M ﹤0.01% 3189

Other funds holding DVAX

Bank of New York Mellon's DVAX Position: Q1 2026 in Review

Bank of New York Mellon sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 558,522 shares — an estimated $8.59M sold.

Bank of New York Mellon first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $20.1M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Bank of New York Mellon reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 558,522 Dynavax Technologies shares in Q1 2026, an estimated $8.59M.
  • Bank of New York Mellon first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
  • Bank of New York Mellon's Dynavax Technologies position peaked at $20.1M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.